Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E E Sugg

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.
Journal of Medicinal Chemistry|January 19, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"C J Aquino, D R Armour, J M Berman, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.
Journal of Medicinal Chemistry|January 19, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger"C J Aquino, D R Armour, J M Berman, et al.
Pageof 3